TABLE 3.
Representative antidiabetic flavonoids.
| Bioactive metabolites | Detail | Cell lines/model | Dose | Negative/positive control | Duration | References |
|---|---|---|---|---|---|---|
| Apigenin | Neutralized active oxygen and enhanced the activity of antioxidant enzymes to achieve anti-oxidation | Alloxan-induced diabetic mice | 0.78 mg/kg | NC: saline (0.1 ml) | 10 days | Panda and Kar, (2007) |
| Baicalein | Activated AMPK to achieve anti-inflammatory function and inhibit IR | HFD-induced mice | 400 mg/kg | — | 29 weeks | Pu et al. (2012) |
| Downregulated related genes SREBP-1c, FAS, key enzymes for cholesterol and fatty acid synthesis to regulate lipid metabolism | HFD-induced Rats | 80 mg/kg | NC: saline | 18 weeks | Guo et al. (2009) | |
| Puerarin | Inhibited NOX4, NOX2, and NF-κB | STZ-induced diabetic rats | 18, 45 mg/kg | — | 3 weeks | Li et al. (2016) |
| Reduced ROS and renewed the activities of antioxidant enzymes | Lead-induced Rats | 200 mg/kg | NC: saline (0.9% NaCl) | 75 days | Liu et al. (2011) | |
| Upregulated the mRNA levels of endogenous antioxidant enzymes | Preadipocyte 3T3-L1 cell | 100 μM | — | 6 days | Lee K. M et al. (2010) | |
| Inhibitied NF-κB-driven liver inflammation and the TGF-β/smad signaling pathway | HFD-induced diabetic rats | 100 mg/kg | — | 8 weeks | Hou et al. (2018) | |
| lower blood glucose levels | STZ-induced diabetic rats | 15 mg/kg | NC: saline | 2 weeks | Hsu et al. (2003) | |
| Decreased the blood glucose level of T2DM by downregulating ADRP mRNA expression and depressing IR | HFD-induced Diabetic Rats | 40, 80, and 160 mg/kg | NC: saline | 6 weeks | Sun et al. (2008) | |
| Activated GLP-1R signaling | HFD-induced Diabetic Mice | 150 mg/kg | — | 35 days | Yang et al. (2016) | |
| Reduced pancreatic tissue damage and upregulated IRS-1 and IGF-1 | STZ-induced diabetic mice | 20, 40, and 80 mg/kg | PC: metformin (40 mg/kg) | 14 days | Wu et al. (2013) | |
| Quercetin | Inhibited the generation of free radicals, enhanced the activity of antioxidant enzymes, and reduced the content of MDA and NO | STZ-induced broilers | 0.2, 0.4, and 0.6 g/kg | — | 42 days | Ying et al. (2020) |
| Promoted insulin secretion through the ERK1/2 pathway | INS-1 cells | 20 μM | — | 5 days | Youl et al. (2010) | |
| Inhibited COX and LOX | RLE cells | 10, 20 μM | — | 24 h | Lee O. H et al. (2010) | |
| Blocked the production of pro-inflammatory cytokines | Orbital fat tissues | 100 μM | — | 72 h | Yoon et al. (2012) | |
| Activated AMPK pathway to inhibit adipogenesis | 3T3-L1 cells | 0, 10, 50, and 100 μM | — | 8 days | Ahn et al. (2008) | |
| Quercitrin | Restored glycogen content and carbohydrate metabolic enzyme activities | STZ-induced diabetic rats | 30 mg/kg | NC: carboxymethyl cellulose (1 ml/rat) | 30 days | Babujanarthanam et al. (2010) |
| Decreased fasting blood glucose, increased insulin levels, and improved the antioxidant status | STZ-induced diabetic rats | 30 mg/kg | NC: carboxymethyl cellulose (1 ml/rat) | 30 days | Babujanarthanam et al. (2011) | |
| Hesperidin | Inhibited the generation of ROS and reduced the content of MDA | Exhausted exercise model in rats | 200 mg/kg | — | 52 days | Estruel-Amades et al. (2019) |
| Inhibited cell apoptosis by reducing the levels of Caspase-9, Caspase-3, and Bax/Bcl-2 | The retinal ganglion cell 5 (RGC-5) cells | 12.5, 25, and 50 μM | — | 48 h | Liu et al. (2017) | |
| Suppression of systemic levels of IL-6, MCP-1, and TBARS | HFD-induced C57BL/6J mice | 100 mg/kg | — | 4 weeks | Ferreira et al. (2016) | |
| Inhibited both amylose and amylopectin digestion | HepG2 cells | 10, 50 μM | PC: Metformin (1,000 μM) | 24 h | Shen et al. (2012) | |
| Inhibited hepatic gluconeogenesis | Rat liver | 40, 80, 120, 160, and 200 μM | — | 24 h | Zareei et al. (2017) | |
| Increased PPAR-γ activity or PPAR-γ mRNA expression | HEK293 cells | 400 and 800 μg/ml EMS | — | 9 weeks | Shin et al. (2013) | |
| Improved the impaired fasting glucose level and glucose tolerance | HFD-induced mice | 1%, 5% EMS (ethanol extract of Prunus mume fruits) | — | 9 weeks | Shin et al. (2013) | |
| Myricetin | Increased GSH level and CAT activity | Adult female Wistar Albino mice | 3 mg/kg | — | 7 days | Hassana et al. (2017) |
| Reduced MDA and oxidation protein | MC3T3-E1 cell | 0.01–10 μM | — | 2 days | Lee and Choi, (2008) | |
| Inhibition of NF-κB-mediated inflammatory responses | LPS-induced mice | 120 mg/kg | PC: dexamethasone (0.5 mg/kg) | 4 h | Qi et al. (2017) | |
| Inhibited α-Amylase (α-Amy) and α-Glucosidase (α-Glu) activity | Pancreatic α-Amylase, α-Glucosidase | 0.5, 1 μg/ml | — | 20 min | Meng et al. (2016) | |
| Kaempferol | Inhibited the production of ROS, enhanced the activity of antioxidant enzymes, and scavenged free radicals | dRib-induced HIT-T15 cells | 10 μM | — | 30 min | Lee Y. Jet al. (2010) |
| Inhibited the activation of AP-1 | PC3 cells | 50 μM | — | 24 h | Gopalakrishnan et al. (2006) | |
| Ameliorated hyperglycemia as ligands of PPARγ | 3T3-L1 adipocytes | 5, 10, 20, and 50 μM | PC: Rosiglitazone (1 μM) | 7 days | Fang et al. (2008) | |
| Reduced inflammation by downregulation of IKK and inhibition of NF-κB pathway activation | HFD-Induced Rats | 50, 150 mg/kg | PC: Aspirin (100 mg/kg) | 9 weeks | Luo et al. (2015) | |
| Protected pancreatic beta-cell survival and function | INS-1E beta-cells | 10 μM | — | 4 days | Zhang and Liu, (2011) | |
| Luteolin | Reduced oxidative stress and enhanced activity in the NOS–NO pathway | STZ-induced diabetic rats | 10, 50, 100 mg/kg | — | 8 weeks | Qian et al. (2010) |
| Attenuated IR through the activation of AMPKα1 signaling | HFD-induced diabetic mice | 0.01% v/v | — | 20 weeks | Zhang et al. (2016) | |
| RAW 264.7 cells | 20 μM | — | 24 h | |||
| Reduced oxidative stress by elevating the enos expression, enhancing mnsod, and suppressing mptp in the downstream | STZ-induced diabetic rats | 100 mg/kg | — | 2 weeks | Zhou et al. (2021) | |
| Reduced oxidative stress by elevating the eNOS expression, enhancing MnSOD, and suppressing mPTP downstream | STZ-induced diabetic rats | 50 mg/kg | — | 2 weeks | Yang et al. (2015) | |
| Increased the antioxidant capacity such as GSH and gpx activity, and decreased MDA level | STZ-induced diabetic rats | 25, 50, 100 mg/kg | NC: 0.5% CMC | 12 weeks | Chen Y et al. (2017) | |
| Inhibited IL-1β, vascular endothelial growth factor, and NF-κB mRNA and protein expression | ||||||
| Decreased the IL-1β mRNA expression and TNF-α mRNA expression to ameliorate inflammatory | STZ-induced diabetic rats | 50, 100 mg/kg | — | 8 weeks | Gu et al. (2018) |